Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 391, Issue 11, pp 1285–1293 | Cite as

Endothelium-independent vasodilator effect of isocorynoxeine in vitro isolated from the hook of Uncaria rhynchophylla (Miquel)

  • Ting Li
  • Ke Xu
  • Delu Che
  • Zhuangzhuang Huang
  • Nabila Jahan
  • Sicen Wang
Original Article

Abstract

This study was designed to investigate the vasorelaxant effects and underlying mechanism of isocorynoxeine (ICN), one of the indole alkaloids from Uncaria hooks, on isolated mesenteric arteries in vitro. The myograph system was applied for isometric tension recording in the vascular rings. ICN relaxed both endothelium-intact and endothelium-denuded rat vascular rings precontracted with phenylephrine or KCl in a dose-dependent manner. Propranolol, tetraethylammonium, BaCl2, and glibenclamide had no influence on the vasodilator effect of ICN on phenylephrine-primed vascular rings, while 4-aminopyridine decreased the maximum relaxation. Furthermore, ICN produced a significant drop in maximum response in the PE log concentration-response curve without shifting to the right. In the Ca2+-free Kreb’s-Henseleit buffer, ICN inhibited the contraction in vascular rings evoked by PE, but not by KCl. The phasic contractions of segments in the Ca2+-free Kreb’s-Henseleit buffer induced by CaCl2 were restrained by ICN, while contractions elicited by caffeine displayed no differences. Furthermore, the phasic vasodilation of ICN was significantly lower than controls when pretreated with nifedipine and heparin. Both BAYK8644- and PE-evoked responses were significantly inhibited in the presence of 100 μM of ICN in human vascular smooth muscle cells loaded with the fluorescent Ca2+ indicator Fluo-4-AM. All these results suggest that ICN act in an endothelium-independent manner on the mesenteric artery. Its mechanisms of vasorelaxant action were produced by the inhibition of L-type calcium channel-mediated external Ca2+ influx and α1A-adrenoceptor-mediated intracellular Ca2+ release in vascular smooth muscle cells, and the participation of the Kv channel.

Keywords

Isocorynoxeine (ICN) Rat mesenteric artery Vasorelaxation Calcium channel α1A-Adrenoceptor antagonist 

Notes

Acknowledgements

We gratefully acknowledge the National Natural Science Foundation of China (No. 81673398) for financial support.

Author contribution statement

SW and TL conceived of or designed study. TL and KX performed research. TL and NJ analyzed data. ZH and DC contributed new reagents and analytical tools. TL wrote the paper. All authors read and approved the manuscript.

Funding

This study was funded by National Natural Science Foundation of China (No. 81673398).

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving animals were in accordance with the ethical standards of the Ethical Committee of Xi’an Jiaotong University.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Supplementary material

210_2018_1536_Fig7_ESM.png (191 kb)
Supplementary Fig 7

The LC/MS-IT-TOF MS spectra of ICN (GIF 8 kb)

210_2018_1536_MOESM1_ESM.tif (583 kb)
High resolution Image (TIF 583 kb)

References

  1. Bai R, Wei Z, Liu J, Xie W, Yao H, Wu X, Jiang J, Wang Q, Xu J (2012) Synthesis and biological evaluation of 4′-[(benzimidazole-1-yl) methyl] biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists. Bioorg Med Chem 20(15):4661–4667.  https://doi.org/10.1016/j.bmc.2012.06.011 CrossRefPubMedGoogle Scholar
  2. Baltoumas FA, Theodoropoulou MC, Hamodrakas SJ (2013) Interactions of the α-subunits of heterotrimeric G-proteins with GPCRs, effectors and RGS proteins: a critical review and analysis of interacting surfaces, conformational shifts, structural diversity and electrostatic potentials. J Struct Biol 182(3):209–218.  https://doi.org/10.1016/j.jsb.2013.03.004 CrossRefPubMedGoogle Scholar
  3. Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature 361(6410):315–325.  https://doi.org/10.1111/j.1749-6632.1995.tb26646 CrossRefPubMedGoogle Scholar
  4. Carretero OA, Oparil S (2000) Essential hypertension. Circulation 101(3):329–335.  https://doi.org/10.1161/01.CIR.101.3.329 CrossRefPubMedGoogle Scholar
  5. Chen YP, Lu MN, Hao JC, Li MH, Hattori M, Wang W (2015) Metabolites of isocorynoxeine in rats after its oral administration. J Asian Nat Prod Res 17(4):384–390.  https://doi.org/10.1080/10286020.2014.1003182 CrossRefPubMedGoogle Scholar
  6. Cheng JT (2000) Drug therapy in Chinese traditional medicine. J Clin Pharmacol 40(5):445–450.  https://doi.org/10.1177/00912700022009198 CrossRefPubMedGoogle Scholar
  7. Chou CH, Gong CL, Chao CC, Lin CH, Kwan CY, Hsieh CL, Leung YM (2009) Rhynchophylline from Uncaria rhynchophylla functionally turns delayed rectifiers into A-Type K+ channels. J Nat Prod 72(5):830–834.  https://doi.org/10.1021/np800729q CrossRefPubMedGoogle Scholar
  8. Crowley CM, Lee CH, Gin SA, Keep AM, Cook RC, van Breemen C (2002) The mechanism of excitation-contraction coupling in phenylephrine-stimulated human saphenous vein. Am J Physiol Heart Circ Physiol 283(4):1271–1281.  https://doi.org/10.1152/ajpheart.01129.2001 CrossRefGoogle Scholar
  9. Ghosh TK, Eis PS, Mullaney JM, Ebert CL, Gill DL (1988) Competitive, reversible, and potent antagonism of inositol 1, 4, 5-trisphosphate-activated calcium release by heparin. J Biol Chem 263(23):11075–11079PubMedGoogle Scholar
  10. Ha KT, Lee TK, Kwak KH, Kim JK, Kim DI, Choi DY, Kim CH (2004) Inhibitory effect of Cho-Deung-San on human aortic smooth muscle cell migration induced by TNF-α through inhibition of matrix metalloproteinase-2 and-9 activity. Vasc Pharmacol 41(3):83–90.  https://doi.org/10.1016/j.vph.2004.05.003 CrossRefGoogle Scholar
  11. Habib GB, Basra SS (2014) Are there any new pharmacologic therapies on the horizon to better treat hypertension? A state-of-the-art paper. J Cardiovasc Pharmacol Ther 19(6):516–525.  https://doi.org/10.1177/1074248414529620 CrossRefPubMedGoogle Scholar
  12. Hanus JS, Amboni G, Rosa MI, Ceretta LB, Tuon L (2015) The quality and characteristics of sleep of hypertensive patients. Rev Esc Enferm U S P 49(4):0596–0602.  https://doi.org/10.1590/S0080-623420150000400009 CrossRefGoogle Scholar
  13. He J, Han S, Yang F, Zhou N, Wang S (2012) Prostate cell membrane chromatography–liquid chromatography–mass spectrometry for screening of active constituents from Uncaria rhynchophylla. J Chromatogr Sci 51(10):905–909.  https://doi.org/10.1093/chromsci/bms188 CrossRefPubMedGoogle Scholar
  14. Huang ZQ, Liu JL, Wang YY, Ling YP, Li D (2008) A study on the chemical change in the decoction of Uncaria hook. J Northwest 38(5):787–789Google Scholar
  15. Kang TH, Murakami Y, Takayama H, Kitajima M, Aimi N, Watanabe H, Matsumoto K (2004) Protective effect of rhynchophylline and isorhynchophylline on in vitro ischemia-induced neuronal damage in the hippocampus: putative neurotransmitter receptors involved in their action. Life Sci 76(3):331–343.  https://doi.org/10.1016/j.lfs.2004.08.012 CrossRefPubMedGoogle Scholar
  16. Keji C, Hao X (2003) The integration of traditional Chinese medicine and Western medicine. Eur Rev 11(2):225–235.  https://doi.org/10.1017/S106279870300022X CrossRefGoogle Scholar
  17. Kushida H, Fukutake M, Tabuchi M, Katsuhara T, Nishimura H, Ikarashi Y, Kanitani M, Kase Y (2013) Simultaneous quantitative analyses of indole and oxindole alkaloids of Uncaria Hook in rat plasma and brain after oral administration of the traditional Japanese medicine Yokukansan using high-performance liquid chromatography with tandem mass spectrometry. Biomed Chromatogr 27(12):1647–1656.  https://doi.org/10.1002/bmc.2974 CrossRefPubMedGoogle Scholar
  18. Laus G, Keplinger K (2003) Alkaloids of peruvian Uncaria guianensis (Rubiaceae). Phyton 43(1):1–8Google Scholar
  19. Laus G, Teppner H (1996) Alkaloids of an Uncaria rhynchophylla (Rubiaceae-Coptosapelteae). Phyton 36:185–196Google Scholar
  20. Li YJ, Bao JX, Xu JW, Murad F, Bian K (2010) Vascular dilation by paeonol—a mechanism study. Vasc Pharmacol 53(3):169–176.  https://doi.org/10.1016/j.vph.2010.07.001 CrossRefGoogle Scholar
  21. Li PY, Zeng XR, Cheng J, Wen J, Inoue I, Yang Y (2013) Rhynchophylline-induced vasodilation in human mesenteric artery is mainly due to blockage of L-type calcium channels in vascular smooth muscle cells. Naunyn Schmiedeberg’s Arch Pharmacol 386(11):973–982.  https://doi.org/10.1007/s00210-013-0888-6 CrossRefGoogle Scholar
  22. Liu SH, Zeng XR, Yin L (2007) The effect of rhynchophylline on large-conductance calcium-activated potassium channels of human mesenteric artery smooth muscle cells. Sichuan J Physiol Sci 29(3):97–99Google Scholar
  23. Martini LC, Garcezdocarmo L, Jurkiewicz A (2010) Functional classification of non-competitive antagonism in vas deferens. Ann N Y Acad Sci 812(1):196–199.  https://doi.org/10.1111/j.1749-6632.1997.tb48172.x CrossRefGoogle Scholar
  24. Metzler M, Pfeiffer E, Schulz SI, Dempe JS (2013) Curcumin uptake and metabolism. Biofactors 39(1):14–20.  https://doi.org/10.1002/biof.1042 CrossRefPubMedGoogle Scholar
  25. Qian LB, Wang HP, Qiu WL, Huang H, Bruce IC, Xia Q (2006) Interleukin-2 protects against endothelial dysfunction induced by high glucose levels in rats. Vasc Pharmacol 45(6):374–382.  https://doi.org/10.1016/j.vph.2006.06.002 CrossRefGoogle Scholar
  26. Ridsdale CE (1978) A revision of Mitragyna and Uncaria (Rubiaceae). Blumea 24(1):43–100Google Scholar
  27. Sanae F, Komatsu Y, Amagaya S, Chisaki K, Hayashi H (2000) Effects of 9 Kampo medicines clinically used in hypertension on hemodynamic changes induced by theophylline in rats. Biol Pharm Bull 23(6):762–765.  https://doi.org/10.1248/bpb.23.762 CrossRefPubMedGoogle Scholar
  28. Schild HO (1954) Non-competitive drug antagonism. J Physiol 124(2):33–34PubMedGoogle Scholar
  29. Shimada Y, Yang Q, Yokoyama K, Goto H, Kasahara Y, Sekiya N, Hikiami H, Terasawa K (2003) Choto-san prevents occurrence of stroke and prolongs life span in stroke-prone spontaneously hypertensive rats. Am J Chin Med 31(01):79–85.  https://doi.org/10.1142/S0192415X03000837 CrossRefPubMedGoogle Scholar
  30. Song CQ, Fan Y, Huang WH (2003) Different hypotensive effects of various active constituents isolated from Uncaria rhynchophylla. Chin Tradit Herb Drugs 31(10):762–764Google Scholar
  31. Tao SU, Rui LI, Cao YX (2011) Vasorelaxant and antihypertensive effects of formononetin through endothelium-dependent and -independent mechanisms. Acta Pharmacol Sin 32(8):1009–1018.  https://doi.org/10.1038/aps.2011.51 CrossRefGoogle Scholar
  32. Wu YT, Lin LC, Tsai TH (2014) Determination of rhynchophylline and hirsutine in rat plasma by UPLC-MS/MS after oral administration of Uncaria rhynchophylla extract. Biomed Chromatogr 28(3):439–445.  https://doi.org/10.1002/bmc.3052 CrossRefPubMedGoogle Scholar
  33. Yang ZD, Duan DZ, Du J, Yang MJ, Li S, Yao XJ (2012) Geissoschizine methyl ether, a corynanthean-type indole alkaloid from Uncaria rhynchophylla as a potential acetylcholinesterase inhibitor. Nat Prod Res 26(1):22–28.  https://doi.org/10.1080/14786419.2010.529811 CrossRefPubMedGoogle Scholar
  34. Zhang W, Liu GX, Huang XN (1987) Effect of rhynchophylline on the contraction of rabbit aorta. Acta Pharmacol Sin 8(5):425–429Google Scholar
  35. Zhang WB, Chen CX, Sim SM, Kwan CY (2004) In vitro vasodilator mechanisms of the indole alkaloids rhynchophylline and isorhynchophylline, isolated from the hook of Uncaria rhynchophylla (Miquel). Naunyn Schmiedeberg's Arch Pharmacol 369(2):232–238.  https://doi.org/10.1007/s00210-003-0854-9 CrossRefGoogle Scholar
  36. Zhang YN, Yang YF, Xu W, Yang XW (2017) The blood-brain barrier permeability of six indole alkaloids from Uncariae Ramulus Cum Uncis in the MDCK-pHaMDR cell monolayer model. Molecules 22(11):1944.  https://doi.org/10.3390/molecules22111944 CrossRefGoogle Scholar
  37. Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H (2016) Design, synthesis, and biological evaluation of indoline and Indole derivatives as potent and selective α1A-adrenoceptor antagonists. J Med Chem 59(8):3826–3839.  https://doi.org/10.1021/acs.jmedchem.5b02023 CrossRefPubMedGoogle Scholar
  38. Zheng JN, Wang DY (2009) Study on alkaloid constituents in Uncaria Macrophylla. Guiding J Trad Chin Med Pharm 15(1):80–86Google Scholar
  39. Zhou J, Zhou S (2010) Antihypertensive and neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activity. J Ethnopharmacol 132(1):15–27.  https://doi.org/10.1016/j.jep.2010.08.041 CrossRefPubMedGoogle Scholar
  40. Zhou JY, Zhou SW (2012) Isorhynchophylline: a plant alkaloid with therapeutic potential for cardiovascular and central nervous system diseases. Fitoterapia 83(4):617–626.  https://doi.org/10.1016/j.fitote.2012.02.010 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.School of PharmacyXi’an Jiaotong University Health Science CenterXi’anPeople’s Republic of China
  2. 2.Shaanxi Engineering Research Center of Cardiovascular Drugs Screening & AnalysisXi’anPeople’s Republic of China
  3. 3.National-Provincial Joint Engineering Research Center for Natural Vascular Medicine Screen & AnalysisXi’anPeople’s Republic of China
  4. 4.Shaanxi Buchang Pharmaceutical Co. LtdXi’anPeople’s Republic of China

Personalised recommendations